Funding Rounds
Oviva

Oviva Series B (2020, $21M)

Oviva

Oviva is digitising the treatment of type 2 diabetes and obesity through our unique behaviour change platform.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $21.00M

Raised Date: 2020-01-01